Ozone-Induced Macrophage Efferocytosis: A Mechanistic Advance in Neuropathic Pain Relief

Study Background and Research Question

Neuropathic pain (NPP) presents a persistent clinical challenge, affecting 7–10% of the population and characterized by spontaneous pain, sensory abnormalities, and hyperalgesia. Existing first-line treatments, such as tricyclic antidepressants and gabapentinoids, often provide inadequate relief and carry significant side effects or risk of tolerance. The accumulation of apoptotic cells and unresolved neuroinflammation are recognized contributors to the pathological cycle of NPP. This context frames the central research question addressed by Ruan et al. (2024): Can targeted augmentation of apoptotic cell clearance, specifically through macrophage efferocytosis, provide a novel therapeutic avenue for neuropathic pain management?

Key Innovation from the Reference Study

The hallmark innovation of this work lies in identifying ozone as a potent enhancer of macrophage efferocytosis, coupled with clear mechanistic elucidation. The study demonstrates, for the first time, that ozone activates the AMPK/Gas6-MerTK/SOCS3 signaling axis in macrophages, resulting in more effective uptake of apoptotic neutrophils. This cascade not only accelerates apoptotic cell clearance but also suppresses pro-inflammatory cytokine expression (IL-1β, IL-6, TNF-α), effectively mitigating neuroinflammation and mechanical hypersensitivity in a mouse model of NPP. These findings underscore both the therapeutic promise of ozone and the translational potential of modulating efferocytosis pathways.

Methods and Experimental Design Insights

To dissect the role of ozone in macrophage-mediated resolution of neuroinflammation, the authors used a chronic constriction injury (CCI) model in mice—a well-established paradigm for mimicking human neuropathic pain. Three concentrations of ozone (15, 30, 45 mg) were administered, with 30 mg yielding optimal outcomes for pain relief and efferocytosis enhancement. Behavioral assays quantified mechanical hypersensitivity, while flow cytometry and phagocytosis assays evaluated the engulfment of apoptotic neutrophils by bone marrow-derived macrophages (BMDMs) in vitro. The study further employed specific inhibitors (AMPK inhibitor CC and MerTK inhibitor UNC2541) to validate pathway dependence, and performed molecular analyses for pathway markers and cytokines. This integrative approach provided both functional and mechanistic validation of the ozone effect.

Protocol Parameters

• Ozone administration: 30 mg concentration delivered to CCI mice for optimal modulation of pain and efferocytosis.
• Phagocytosis assay: BMDMs co-cultured with apoptotic neutrophils post-ozone exposure; quantified by flow cytometry.
• Pathway inhibition: AMPK inhibition (Compound C) and MerTK inhibition (UNC2541) used to confirm signaling specificity in vivo.
• Outcome measures: Mechanical hypersensitivity (behavioral testing), cytokine profiles (ELISA/qPCR), and efferocytosis quantification (microscopy/flow cytometry).

Core Findings and Why They Matter

The study’s central finding is that ozone at 30 mg not only alleviates mechanical hypersensitivity in CCI mice but also markedly increases the phagocytic capacity of macrophages for apoptotic cells. Mechanistically, ozone upregulates AMPK activation, selectively boosts expression of Gas6 (a MerTK ligand), and enhances MerTK signaling, culminating in increased SOCS3 expression and robust suppression of inflammatory cytokines. The specificity of this pathway was evidenced by the abolition of ozone’s effect upon pharmacological inhibition of AMPK or MerTK. These results position the AMPK/Gas6-MerTK/SOCS3 axis as a viable therapeutic target for interrupting the pain-inflammation cycle characteristic of neuropathic pain (internal review).

Comparison with Existing Internal Articles

Several internal resources contextualize and extend the translational relevance of these findings:

• "BCECF: Shaping Translational pH Sensing in Neuropathic Pain Models" discusses the strategic integration of BCECF (2',7'-bis(carboxyethyl)-5(6)-Carboxyfluorescein) as a ratiometric fluorescent probe for monitoring extracellular pH shifts during immune and pain modulation experiments, including those involving the AMPK/Gas6-MerTK/SOCS3 pathway.
• "BCECF: Advanced Strategies for Extracellular pH Sensing in Disease Models" provides practical guidance for leveraging BCECF in microenvironmental pH regulation assays, which are critical for dissecting the metabolic consequences of neuroinflammation and efferocytosis in pain models.
• The present reference study bridges mechanistic advances in immunology with practical requirements in experimental design—such as the need for precise extracellular pH measurement when evaluating ion transport or cellular metabolism during efferocytosis-driven inflammation resolution.

Limitations and Transferability

While the evidence for ozone’s role in enhancing macrophage efferocytosis is compelling, several limitations merit consideration. The study is conducted exclusively in murine models, and the dose-response relationship of ozone may differ in other species or in clinical contexts. Furthermore, the molecular specificity of ozone’s effect—particularly potential off-target responses or long-term safety—requires further elucidation. The reliance on a single model of neuropathic pain (CCI) also limits immediate generalizability to other pain etiologies or chronic inflammatory conditions. Finally, while the AMPK/Gas6-MerTK/SOCS3 axis is clearly implicated, the full landscape of interacting pathways remains to be mapped.

Research Support Resources

For researchers designing workflows to probe the metabolic and microenvironmental dynamics of efferocytosis and neuroinflammation, robust extracellular pH measurement tools are essential. BCECF (2',7'-bis(carboxyethyl)-5(6)-Carboxyfluorescein) (SKU C5694) is a widely used, cell-impermeant, ratiometric fluorescent pH probe, well-suited for quantitative assays of extracellular or compartmental pH in biomedical research. The probe’s selectivity and sensitivity support advanced ion transport, acid-base homeostasis, and microenvironmental regulation studies relevant to the pathways described above. For detailed application protocols and troubleshooting, see APExBIO’s product documentation and the workflow recommendations in recent internal articles.